TMPRSS2-ETS rearrangements were later characterized in prostate cancer metastases and different metastatic sites from the same patients were found to harbor the same molecular sub-type of gene fusion events, indicating clonal expansion of advanced disease from a single primary focus (Mehra et al., 2008). The gene discussed is TMPRSS2; the disease is prostate cancer.